Age-related changes of vitamin C levels in aqueous humour

Vladimir Čanadanović; Slobodanka Latinović; Sava Barišić; Nikola Babić; Sandra Jovanović

doi:10.2298/5124

Vladimir Čanadanović Eye Clinic, Clinical Center of Vojvodina, Novi Sad, Serbia; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Slobodanka Latinović Eye Hospital “VIDAR-ORASIS Swiss”, Novi Sad, Serbia
Sava Barišić Eye Clinic, Clinical Center of Vojvodina, Novi Sad, Serbia
Nikola Babić Eye Clinic, Clinical Center of Vojvodina, Novi Sad, Serbia; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Sandra Jovanović Eye Clinic, Clinical Center of Vojvodina, Novi Sad, Serbia; Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia

DOI: https://doi.org/10.2298/5124

Keywords: cataract, aqueous humor, aging, ascorbic acid, chromatography,

Abstract

Background/Aim. Age-related cataract is a common disease among senior population. Vitamin C is the most effective reducing hydrosoluble antioxidant causing reduction in the levels of free radicals in crystaline lens. The aim of this study was to evaluate the age-related change of vitamin C (L-ascorbic acid) level in the aqueous humor of patients with senile cataract. Methods. This prospective study included 74 patients, divided into 3 age groups, with age-related cataract, underwent routine phaco cataract surgery with intraocular lens implantation. Aqueous humor was aspirated from 74 eyes at the beginning of phacoemulsification. The levels of vitamin C (L-ascorbic acid) in aqueous humor were determined with high-performance liquid chromatography (HPLC). Results. The average age of patients included in the study was 65 ± 9.85 years (54–87 years). The level of vitamin C in aqueous humor was 152.78 ± 7.0125 µg/mL in the group A (50–59 years), 134.15 ± 5.1569 µg/mL in the group B (60–69 years) and 106.51 ± 5.44 µg/mL in the group C (over 70 years). Conclusion. The amount of vitamin C in aqueous humor of patients with age-related cataract is decreasing with age. There was a statistically significant change (p < 0.001) of vitamin C aqueous concentration in the patients of different age. This decrease could play a role in susceptibility to cataract formation in older population.

References

Robman L, Taylor H. External factors in the development of cataract. Eye 2005; 19(10): 1074−82.

Zoric L, Elek-Vlajic S, Jovanovic M, Kisic B, Djokic O, Canadanovic V, et al. Oxidative stress intensity in lens and aqueous depending on age-related cataract type and brunescense. Eur J Ophthalmol 2008; 18(5): 669−74.

Hekimi S, Lapointe J, Wen Y. Taking a "good" look at free radi-cals in the aging process. Trends In Cell Biology 2011; 21(10): 569−76.

Candia OA. Electrolyte and fluid transport across corneal, con-junctival and lens epithelia. Exp Eye Res 2004; 78(3): 527−35.

Chong EW, Wong TY. Multivitamin supplements and cataract prevention. Ophthalmology 2008; 115(4): 597−8.

Seddon JM. Multivitamin-multi mineral supplements and eye disease: age-related macular degeneration and cataract. Am J Clin Nutr 2007; 85(1): 304S−7S.

Boscia F, Grattagliano I, Vendemiale G, Micelli-Ferrari T, Altomare E. Protein oxidation and lens opacity in humans. Invest Oph-thalmol Vis Sci 2000; 41(9): 2461−5.

Sies H. Oxidative stress: Oxidants and antioxidants. Exp Physiol 1997; 82(2): 291−5.

Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr Rev 2012; 70(5): 257−65.

Michels A, Frei B. Vitamin C. In: Caudill MA, Rogers M, editors. Biochemical, Physiological, and Molecular Aspects of Human Nutrition. Philadelphia: W B Saunders; 2012.

Clinical Trial of Nutritional Supplements and Age-Related Cataract Study Group, Maraini G, Williams SL, Sperduto RD, Ferris F, Milton RC, Clemons TE, et al. A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities. Ophthalmology 2008; 115(4): 599−607.

Valero MP, Fletcher AE, de Stavola BL, Vioque J, Alepuz VC. Vita-min C is associated with reduced risk of cataract in a Mediterranean population. J Nutr 2002; 132: 1299−306.

Gritz DC, Srinivasan M, Smith SD, Kim U, Lietman TM, Wilkins JH, et al. The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India. Br J Ophthalmol 2006; 90(7): 847−51.

Simpson GL, Ortwerth BJ. The non-oxidative degradation of ascorbic acid at physiological conditions. Biochim Biophys Acta 2000; 1501(1): 12−24.

Foster PJ, Wong TY, Machin D, Johnson GJ, Seah SK. Risk factors for nuclear, cortical and posterior subcapsular cataracts in the Chinese population of Singapore: the Tanjong Pagar Survey. Br J Ophthalmol 2003; 87(9): 1112−20.

Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metab Rev 2000; 32(3−4): 307−26.

Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH, et al. Vi-tamin C as an antioxidant: Evaluation of its role in disease prevention. J Am Coll Nutr 2003; 22(1): 18−35.

Bleau G, Giasson C, Brunette I. Measurement of hydrogen perox-ide in biological samples containing high levels of ascorbic acid. Anal Biochem 1998; 263(1): 13−7.

Jacques PF, Chylack LT, McGandy RB, Hartz SC. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol 1988; 106(3): 337−40.

Bhuyan KC, Bhuyan DK. Lipid perozidation in cataract of the human. Life Sci 1986; 38(16): 1463−71.

Spector A, Garner WH. Hydrogen peroxide and human cataract. Exp Eye Res 1981; 33(6): 673−81.

Jacques PF, Chylac LT. Epidemiologic evidence of role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr 1991; 53(1): 352S−5S.

Chylack LT, Brown NP, Bron A, Hurst M, Köpcke W, Thien U, et al. The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol 2002; 9(1): 49−80.

Sperduto RD, Hu TS, Milton RC, Zhao JL, Everett DF, Cheng QF, et al. The Linxian cataract studies. Two nutrition intervention trials. Arch Ophthalmol 1993; 111(9): 1246−53.

Klein BE, Knudtson MD, Lee KE, Reinke JO, Danforth LG, Wealti AM, et al. Supplements and age-related exe conditions. Oph-thalmolgy 2008; 115(7): 1203−8.

Cui YH, Jing CX, Pan HW. Association of blood antioxidants and vitamins with risk of age-related cataract: a meta-analysis of observational studies. Am J Clin Nutr 2013; 98(3): 778−86.

Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological func-tions and human disease. Int J Biochem Cell Biol 2007; 39(1): 44−84.

Linetsky M, Shipova E, Cheng R, Ortwerth BJ. Glycation by ascor-bic acid oxidation products leads to the aggregation of lens proteins. Biochim Biophys Acta 2008; 1782(1): 22−34.

Linetsky M, James HL, Ortwerth BJ. Spontaneous generation of superoxide anion by human lens proteines and by calf lens proteins ascorbylated in vitro. Exp Eye Res 1999; 69(2): 239−48.

Fan X, Reneker LW, Obrenovich ME, Strauch C, Cheng R, Jarvis SM, et al. Vitamin C mediates chemical aging of lens crystallins by Maillard reaction in humanized mouse model. Proc Natl Acd Sci USA 2006; 103(45): 16912−7.

Rautiainen S, Lindblad BE, Morgenstern R, Wolk A. Vitamin C supplements and the risk of age-related cataract: a population-based prospective cohort study in women. Am J Clin Nutr 2010; 91(2): 487−93.

Selin JZ, Rautiainen-Lindblad BE, Morgenstern R, Wolk A. High-dose supplements of vitamin C nd E, low dose multivitamins, and the risk of age-related cataract: a population-based pro-spective cohort study of men. Am J Epidemiol 2013; 177(6): 548−55.

Jacques PF, Taylor A, Hankinson SE, Willett WC, Mahnken B, Lee Y, et al. Long term vitamin C supplement use and prevalence of early age-related lens opacities. Am J Clin Nutr 1997; 66(4): 911−6.

Rock CL. Multivitamin-multi mineral supplements: who uses them? Am J Clin Nutr 2007; 85(1): 277S−9S.